context stringlengths 21 33.9k | category stringclasses 2 values | entity stringlengths 1 12 | entity_type stringclasses 5 values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). | text | 42.7 | monetaryItemType | text: <entity> 42.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). </context> | us-gaap:CededPremiumsEarned |
The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). | text | 6.5 | monetaryItemType | text: <entity> 6.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). </context> | us-gaap:CededPremiumsEarned |
The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). | text | 416.8 | monetaryItemType | text: <entity> 416.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). </context> | us-gaap:Assets |
The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). | text | 416.8 | monetaryItemType | text: <entity> 416.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). </context> | us-gaap:Liabilities |
The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). | text | 417.1 | monetaryItemType | text: <entity> 417.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). </context> | us-gaap:Assets |
The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). | text | 417.1 | monetaryItemType | text: <entity> 417.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized ceded premiums written related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ Nil ). In addition, the Company recognized ceded premiums earned related to the ceded reinsurance contracts with Tailwind Re of $ 42.7 million during 2024 (2023 - $ 6.5 million). At December 31, 2024, the total assets and total liabilities of Tailwind Re were $ 416.8 million and $ 416.8 million, respectively (2023 - $ 417.1 million and $ 417.1 million, respectively). </context> | us-gaap:Liabilities |
The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). | text | 3.6 | monetaryItemType | text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). </context> | us-gaap:EquityMethodInvestments |
The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). | text | 4.4 | monetaryItemType | text: <entity> 4.4 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). </context> | us-gaap:EquityMethodInvestments |
The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). | text | 3.0 | monetaryItemType | text: <entity> 3.0 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). </context> | us-gaap:Assets |
The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). </context> | us-gaap:Liabilities |
The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). | text | 5.0 | monetaryItemType | text: <entity> 5.0 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). </context> | us-gaap:Assets |
The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s direct equity ownership in the AlphaCat Funds and AlphaCat Re is included in other investments and was $ 3.6 million at December 31, 2024 (2023 - $ 4.4 million). At December 31, 2024, the total assets and total liabilities of the AlphaCat Funds, AlphaCat Re and OmegaCat Re were $ 3.0 billion and $ 1.3 billion, respectively (2023 - $ 5.0 billion and $ 2.4 billion, respectively). </context> | us-gaap:Liabilities |
The aggregate authorized capital of RenaissanceRe is 325 million shares consisting of 225 million common shares and 100 million preference shares. The following table is a summary of changes in common shares issued and outstanding: | text | 225 | sharesItemType | text: <entity> 225 </entity> <entity type> sharesItemType </entity type> <context> The aggregate authorized capital of RenaissanceRe is 325 million shares consisting of 225 million common shares and 100 million preference shares. The following table is a summary of changes in common shares issued and outstanding: </context> | us-gaap:CommonStockSharesAuthorized |
The aggregate authorized capital of RenaissanceRe is 325 million shares consisting of 225 million common shares and 100 million preference shares. The following table is a summary of changes in common shares issued and outstanding: | text | 100 | sharesItemType | text: <entity> 100 </entity> <entity type> sharesItemType </entity type> <context> The aggregate authorized capital of RenaissanceRe is 325 million shares consisting of 225 million common shares and 100 million preference shares. The following table is a summary of changes in common shares issued and outstanding: </context> | us-gaap:PreferredStockSharesAuthorized |
On May 26, 2023, the Company completed an offering of 7,245,000 of its common shares at the public offering price of $ 192.00 per share. The Company received net proceeds of approximately $ 1,352 million from the equity offering after deducting the underwriting discounts and estimated offering expenses payable by the Company. The Company used the net proceeds from this offering to fund a portion of the cash consideration for the Validus Acquisition, which closed on November 1, 2023, to pay related costs and expenses, and for general corporate purposes. | text | 7245000 | sharesItemType | text: <entity> 7245000 </entity> <entity type> sharesItemType </entity type> <context> On May 26, 2023, the Company completed an offering of 7,245,000 of its common shares at the public offering price of $ 192.00 per share. The Company received net proceeds of approximately $ 1,352 million from the equity offering after deducting the underwriting discounts and estimated offering expenses payable by the Company. The Company used the net proceeds from this offering to fund a portion of the cash consideration for the Validus Acquisition, which closed on November 1, 2023, to pay related costs and expenses, and for general corporate purposes. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
On May 26, 2023, the Company completed an offering of 7,245,000 of its common shares at the public offering price of $ 192.00 per share. The Company received net proceeds of approximately $ 1,352 million from the equity offering after deducting the underwriting discounts and estimated offering expenses payable by the Company. The Company used the net proceeds from this offering to fund a portion of the cash consideration for the Validus Acquisition, which closed on November 1, 2023, to pay related costs and expenses, and for general corporate purposes. | text | 192.00 | perShareItemType | text: <entity> 192.00 </entity> <entity type> perShareItemType </entity type> <context> On May 26, 2023, the Company completed an offering of 7,245,000 of its common shares at the public offering price of $ 192.00 per share. The Company received net proceeds of approximately $ 1,352 million from the equity offering after deducting the underwriting discounts and estimated offering expenses payable by the Company. The Company used the net proceeds from this offering to fund a portion of the cash consideration for the Validus Acquisition, which closed on November 1, 2023, to pay related costs and expenses, and for general corporate purposes. </context> | us-gaap:SaleOfStockPricePerShare |
On May 26, 2023, the Company completed an offering of 7,245,000 of its common shares at the public offering price of $ 192.00 per share. The Company received net proceeds of approximately $ 1,352 million from the equity offering after deducting the underwriting discounts and estimated offering expenses payable by the Company. The Company used the net proceeds from this offering to fund a portion of the cash consideration for the Validus Acquisition, which closed on November 1, 2023, to pay related costs and expenses, and for general corporate purposes. | text | 1352 | monetaryItemType | text: <entity> 1352 </entity> <entity type> monetaryItemType </entity type> <context> On May 26, 2023, the Company completed an offering of 7,245,000 of its common shares at the public offering price of $ 192.00 per share. The Company received net proceeds of approximately $ 1,352 million from the equity offering after deducting the underwriting discounts and estimated offering expenses payable by the Company. The Company used the net proceeds from this offering to fund a portion of the cash consideration for the Validus Acquisition, which closed on November 1, 2023, to pay related costs and expenses, and for general corporate purposes. </context> | us-gaap:SaleOfStockConsiderationReceivedOnTransaction |
On November 1, 2023, the Company issued 1,322,541 of its common shares to AIG pursuant to the Stock Purchase Agreement, as a part of the total consideration for the Validus Acquisition. | text | 1322541 | sharesItemType | text: <entity> 1322541 </entity> <entity type> sharesItemType </entity type> <context> On November 1, 2023, the Company issued 1,322,541 of its common shares to AIG pursuant to the Stock Purchase Agreement, as a part of the total consideration for the Validus Acquisition. </context> | us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued |
In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F | text | 250.0 | monetaryItemType | text: <entity> 250.0 </entity> <entity type> monetaryItemType </entity type> <context> In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F </context> | us-gaap:ProceedsFromIssuanceOrSaleOfEquity |
In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F | text | 10000 | sharesItemType | text: <entity> 10000 </entity> <entity type> sharesItemType </entity type> <context> In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F | text | 5.75 | percentItemType | text: <entity> 5.75 </entity> <entity type> percentItemType </entity type> <context> In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F </context> | us-gaap:PreferredStockDividendRatePercentage |
In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F | text | 1.00 | perShareItemType | text: <entity> 1.00 </entity> <entity type> perShareItemType </entity type> <context> In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F | text | 25000 | perShareItemType | text: <entity> 25000 </entity> <entity type> perShareItemType </entity type> <context> In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F </context> | us-gaap:PreferredStockLiquidationPreference |
In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F | text | 10000000 | sharesItemType | text: <entity> 10000000 </entity> <entity type> sharesItemType </entity type> <context> In June 2018, RenaissanceRe raised $ 250.0 million through the issuance of 10,000 shares of its 5.75 % Series F Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 5.75 % Series F </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
Preference Share). The 5.75 % Series F Preference Shares may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after June 30, 2023, provided that no redemption may occur prior to June 30, 2028 unless certain redemption requirements are met. | text | 5.75 | percentItemType | text: <entity> 5.75 </entity> <entity type> percentItemType </entity type> <context> Preference Share). The 5.75 % Series F Preference Shares may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after June 30, 2023, provided that no redemption may occur prior to June 30, 2028 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockDividendRatePercentage |
Preference Share). The 5.75 % Series F Preference Shares may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after June 30, 2023, provided that no redemption may occur prior to June 30, 2028 unless certain redemption requirements are met. | text | 25000 | perShareItemType | text: <entity> 25000 </entity> <entity type> perShareItemType </entity type> <context> Preference Share). The 5.75 % Series F Preference Shares may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after June 30, 2023, provided that no redemption may occur prior to June 30, 2028 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockRedemptionPricePerShare |
Preference Share). The 5.75 % Series F Preference Shares may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after June 30, 2023, provided that no redemption may occur prior to June 30, 2028 unless certain redemption requirements are met. | text | 25.00 | perShareItemType | text: <entity> 25.00 </entity> <entity type> perShareItemType </entity type> <context> Preference Share). The 5.75 % Series F Preference Shares may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after June 30, 2023, provided that no redemption may occur prior to June 30, 2028 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockRedemptionPricePerShare |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 500.0 | monetaryItemType | text: <entity> 500.0 </entity> <entity type> monetaryItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:ProceedsFromIssuanceOrSaleOfEquity |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 20000 | sharesItemType | text: <entity> 20000 </entity> <entity type> sharesItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 4.20 | percentItemType | text: <entity> 4.20 </entity> <entity type> percentItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockDividendRatePercentage |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 1.00 | perShareItemType | text: <entity> 1.00 </entity> <entity type> perShareItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 25000 | perShareItemType | text: <entity> 25000 </entity> <entity type> perShareItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockLiquidationPreference |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 20000000 | sharesItemType | text: <entity> 20000000 </entity> <entity type> sharesItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 25000 | perShareItemType | text: <entity> 25000 </entity> <entity type> perShareItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockRedemptionPricePerShare |
In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. | text | 25.00 | perShareItemType | text: <entity> 25.00 </entity> <entity type> perShareItemType </entity type> <context> In July 2021, RenaissanceRe raised $ 500.0 million through the issuance of 20,000 shares of its 4.20 % Series G Preference Shares, $ 1.00 par value and liquidation preference $ 25,000 per share (equivalent to 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a 4.20 % Series G Preference Share). The 4.20 % Series G Preference Shares have no stated maturity date and may be redeemed at a redemption price of $ 25,000 per share (equivalent to $ 25.00 per Depositary Share), plus declared and unpaid dividends, at RenaissanceRe’s option on or after July 15, 2026, provided that no redemption may occur prior to July 15, 2026 unless certain redemption requirements are met. </context> | us-gaap:PreferredStockRedemptionPricePerShare |
The amount of the dividend on the 5.750 % Series F Preference Shares is an amount per share equal to 5.750 % of the liquidation preference per annum (the equivalent to $ 1,437.50 per 5.750 % Series F Preference Share per annum, or $ 359.375 per 5.750 % Series F Preference Share per quarter, or $ 1.4375 per Depositary Share per annum, or $ 0.359375 per Depositary Share per quarter). The amount of the dividend on the 4.20 % Series G Preference Shares is an amount per share equal to 4.20 % of the liquidation preference per annum (the equivalent to $ 1,050 per 4.20 % Series G Preference Share per annum, or $ 262.50 per 4.20 % Series G Preference Share per quarter, or $ 1.05 per Depositary Share per annum, or $ 0.2625 per quarter). | text | 5.750 | percentItemType | text: <entity> 5.750 </entity> <entity type> percentItemType </entity type> <context> The amount of the dividend on the 5.750 % Series F Preference Shares is an amount per share equal to 5.750 % of the liquidation preference per annum (the equivalent to $ 1,437.50 per 5.750 % Series F Preference Share per annum, or $ 359.375 per 5.750 % Series F Preference Share per quarter, or $ 1.4375 per Depositary Share per annum, or $ 0.359375 per Depositary Share per quarter). The amount of the dividend on the 4.20 % Series G Preference Shares is an amount per share equal to 4.20 % of the liquidation preference per annum (the equivalent to $ 1,050 per 4.20 % Series G Preference Share per annum, or $ 262.50 per 4.20 % Series G Preference Share per quarter, or $ 1.05 per Depositary Share per annum, or $ 0.2625 per quarter). </context> | us-gaap:PreferredStockDividendRatePercentage |
The amount of the dividend on the 5.750 % Series F Preference Shares is an amount per share equal to 5.750 % of the liquidation preference per annum (the equivalent to $ 1,437.50 per 5.750 % Series F Preference Share per annum, or $ 359.375 per 5.750 % Series F Preference Share per quarter, or $ 1.4375 per Depositary Share per annum, or $ 0.359375 per Depositary Share per quarter). The amount of the dividend on the 4.20 % Series G Preference Shares is an amount per share equal to 4.20 % of the liquidation preference per annum (the equivalent to $ 1,050 per 4.20 % Series G Preference Share per annum, or $ 262.50 per 4.20 % Series G Preference Share per quarter, or $ 1.05 per Depositary Share per annum, or $ 0.2625 per quarter). | text | 4.20 | percentItemType | text: <entity> 4.20 </entity> <entity type> percentItemType </entity type> <context> The amount of the dividend on the 5.750 % Series F Preference Shares is an amount per share equal to 5.750 % of the liquidation preference per annum (the equivalent to $ 1,437.50 per 5.750 % Series F Preference Share per annum, or $ 359.375 per 5.750 % Series F Preference Share per quarter, or $ 1.4375 per Depositary Share per annum, or $ 0.359375 per Depositary Share per quarter). The amount of the dividend on the 4.20 % Series G Preference Shares is an amount per share equal to 4.20 % of the liquidation preference per annum (the equivalent to $ 1,050 per 4.20 % Series G Preference Share per annum, or $ 262.50 per 4.20 % Series G Preference Share per quarter, or $ 1.05 per Depositary Share per annum, or $ 0.2625 per quarter). </context> | us-gaap:PreferredStockDividendRatePercentage |
During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). | text | 35.4 | monetaryItemType | text: <entity> 35.4 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). </context> | us-gaap:DividendsPreferredStock |
During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). | text | 80.8 | monetaryItemType | text: <entity> 80.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). </context> | us-gaap:DividendsCommonStock |
During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). | text | 75.1 | monetaryItemType | text: <entity> 75.1 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). </context> | us-gaap:DividendsCommonStock |
During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). | text | 64.7 | monetaryItemType | text: <entity> 64.7 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company paid $ 35.4 million in preference share dividends (2023 - $ 35.4 million, 2022 - $ 35.4 million) and $ 80.8 million in common share dividends (2023 - $ 75.1 million, 2022 - $ 64.7 million). </context> | us-gaap:DividendsCommonStock |
The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The | text | 2711234 | sharesItemType | text: <entity> 2711234 </entity> <entity type> sharesItemType </entity type> <context> The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The </context> | us-gaap:StockRepurchasedDuringPeriodShares |
The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The | text | 677.6 | monetaryItemType | text: <entity> 677.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The </context> | us-gaap:StockRepurchasedDuringPeriodValue |
The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The | text | 249.93 | perShareItemType | text: <entity> 249.93 </entity> <entity type> perShareItemType </entity type> <context> The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The </context> | us-gaap:TreasuryStockAcquiredAverageCostPerShare |
The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The | text | 287.7 | monetaryItemType | text: <entity> 287.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On November 6, 2024, RenaissanceRe’s Board approved an increase in its authorized share repurchase program to an aggregate amount of up to $ 750.0 million. Unless terminated earlier by RenaissanceRe’s Board, the program will expire when the Company has repurchased the full value of the common shares authorized. During 2024, the Company repurchased 2,711,234 common shares at an aggregate cost of $ 677.6 million and an average price of $ 249.93 per common share. At December 31, 2024, $ 287.7 million remained available for repurchase under the share repurchase program. In the future, the Company may authorize additional purchase activities under the currently authorized share repurchase program, increase the amount authorized under the share repurchase program, or adopt additional trading plans. The </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
In periods for which the Company has net loss allocated to RenaissanceRe common shareholders, the denominator used in calculating net loss attributable to RenaissanceRe common shareholders per common share - basic is also used in calculating net loss attributable to RenaissanceRe common shareholders per common share - diluted. For the year ended December 31, 2022, per common share equivalents of non-vested shares of 90 thousand could potentially be dilutive in future periods if the Company reports net income allocated to RenaissanceRe common shareholders. | text | 90 | sharesItemType | text: <entity> 90 </entity> <entity type> sharesItemType </entity type> <context> In periods for which the Company has net loss allocated to RenaissanceRe common shareholders, the denominator used in calculating net loss attributable to RenaissanceRe common shareholders per common share - basic is also used in calculating net loss attributable to RenaissanceRe common shareholders per common share - diluted. For the year ended December 31, 2022, per common share equivalents of non-vested shares of 90 thousand could potentially be dilutive in future periods if the Company reports net income allocated to RenaissanceRe common shareholders. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 115.1 | monetaryItemType | text: <entity> 115.1 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:PremiumsWrittenGross |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 96.8 | monetaryItemType | text: <entity> 96.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:PremiumsWrittenGross |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 82.0 | monetaryItemType | text: <entity> 82.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:PremiumsWrittenGross |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 119.0 | monetaryItemType | text: <entity> 119.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:AssumedPremiumsEarned |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 83.3 | monetaryItemType | text: <entity> 83.3 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:AssumedPremiumsEarned |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 80.0 | monetaryItemType | text: <entity> 80.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:AssumedPremiumsEarned |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 14.2 | monetaryItemType | text: <entity> 14.2 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 12.7 | monetaryItemType | text: <entity> 12.7 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 15.8 | monetaryItemType | text: <entity> 15.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 31.9 | monetaryItemType | text: <entity> 31.9 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:AccountsReceivableGross |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 37.0 | monetaryItemType | text: <entity> 37.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:AccountsReceivableGross |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 94.5 | monetaryItemType | text: <entity> 94.5 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:ReinsuranceCostsAndRecoveriesNet |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 9.8 | monetaryItemType | text: <entity> 9.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:ReinsuranceCostsAndRecoveriesNet |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 68.6 | monetaryItemType | text: <entity> 68.6 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:ReinsuranceCostsAndRecoveriesNet |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 95.2 | monetaryItemType | text: <entity> 95.2 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense |
During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). | text | 50.2 | monetaryItemType | text: <entity> 50.2 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company recorded $ 115.1 million (2023 - $ 96.8 million, 2022 - $ 82.0 million) of gross premiums written assumed from the Tower Hill Companies and its subsidiaries and affiliates. Gross premiums earned totaled $ 119.0 million (2023 - $ 83.3 million, 2022 - $ 80.0 million) and expenses incurred were $ 14.2 million (2023 - $ 12.7 million, 2022 - $ 15.8 million) for 2024. The Company had a net related outstanding receivable balance of $ 31.9 million as of December 31, 2024 (2023 - receivable of $ 37.0 million). During 2024, the Company assumed net claims and claim expenses of $ 94.5 million (2023 - recovered net claims and claim expenses of $ 9.8 million, 2022 - assumed net claims and claim expenses of $ 68.6 million) and, as of December 31, 2024, had a net reserve for claims and claim expenses of $ 95.2 million (2023 - $ 50.2 million). </context> | us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense |
During 2024, the Company received distributions from Top Layer of $ 16.8 million (2023 - $ 7.8 million, 2022 - $ 8.7 million), and recorded a management fee of $ 3.0 million (2023 - $ 3.4 million, 2022 - $ 2.4 million). The management fee reimburses the Company for services it provides to Top Layer. | text | 3.0 | monetaryItemType | text: <entity> 3.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company received distributions from Top Layer of $ 16.8 million (2023 - $ 7.8 million, 2022 - $ 8.7 million), and recorded a management fee of $ 3.0 million (2023 - $ 3.4 million, 2022 - $ 2.4 million). The management fee reimburses the Company for services it provides to Top Layer. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
During 2024, the Company received distributions from Top Layer of $ 16.8 million (2023 - $ 7.8 million, 2022 - $ 8.7 million), and recorded a management fee of $ 3.0 million (2023 - $ 3.4 million, 2022 - $ 2.4 million). The management fee reimburses the Company for services it provides to Top Layer. | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company received distributions from Top Layer of $ 16.8 million (2023 - $ 7.8 million, 2022 - $ 8.7 million), and recorded a management fee of $ 3.0 million (2023 - $ 3.4 million, 2022 - $ 2.4 million). The management fee reimburses the Company for services it provides to Top Layer. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
During 2024, the Company received distributions from Top Layer of $ 16.8 million (2023 - $ 7.8 million, 2022 - $ 8.7 million), and recorded a management fee of $ 3.0 million (2023 - $ 3.4 million, 2022 - $ 2.4 million). The management fee reimburses the Company for services it provides to Top Layer. | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company received distributions from Top Layer of $ 16.8 million (2023 - $ 7.8 million, 2022 - $ 8.7 million), and recorded a management fee of $ 3.0 million (2023 - $ 3.4 million, 2022 - $ 2.4 million). The management fee reimburses the Company for services it provides to Top Layer. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 82.1 | percentItemType | text: <entity> 82.1 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 84.3 | percentItemType | text: <entity> 84.3 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 82.2 | percentItemType | text: <entity> 82.2 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 32.0 | percentItemType | text: <entity> 32.0 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 36.5 | percentItemType | text: <entity> 36.5 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 13.6 | percentItemType | text: <entity> 13.6 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 36.1 | percentItemType | text: <entity> 36.1 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 33.2 | percentItemType | text: <entity> 33.2 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). | text | 15.0 | percentItemType | text: <entity> 15.0 </entity> <entity type> percentItemType </entity type> <context> During 2024, the Company received 82.1 % of its gross premiums written (2023 - 84.3 %, 2022 - 82.2 %) from three brokers. Subsidiaries and affiliates of Aon plc, Marsh & McLennan Companies, Inc. and Arthur J. Gallagher accounted for 32.0 %, 36.5 % and 13.6 %, respectively, of the Company’s gross premiums written in 2024 (2023 - 36.1 %, 33.2 % and 15.0 %, respectively). </context> | us-gaap:ConcentrationRiskPercentage1 |
0.0 % in Bermuda, 21.0 % in the U.S., 12.5 % in Ireland, 25.0 % in the U.K., 17.0 % in Singapore, 19.7 % in Switzerland, 24.9 % in Luxembourg, 26.5 % in Canada and 30.0 % in Australia | text | 0.0 | percentItemType | text: <entity> 0.0 </entity> <entity type> percentItemType </entity type> <context> 0.0 % in Bermuda, 21.0 % in the U.S., 12.5 % in Ireland, 25.0 % in the U.K., 17.0 % in Singapore, 19.7 % in Switzerland, 24.9 % in Luxembourg, 26.5 % in Canada and 30.0 % in Australia </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
(2023 - increase of $ 19.6 million, 2022 - increase of $ 62.1 million). | text | 19.6 | monetaryItemType | text: <entity> 19.6 </entity> <entity type> monetaryItemType </entity type> <context> (2023 - increase of $ 19.6 million, 2022 - increase of $ 62.1 million). </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
(2023 - increase of $ 19.6 million, 2022 - increase of $ 62.1 million). | text | 62.1 | monetaryItemType | text: <entity> 62.1 </entity> <entity type> monetaryItemType </entity type> <context> (2023 - increase of $ 19.6 million, 2022 - increase of $ 62.1 million). </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. | text | 97.3 | monetaryItemType | text: <entity> 97.3 </entity> <entity type> monetaryItemType </entity type> <context> In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. </context> | us-gaap:OperatingLossCarryforwards |
In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. | text | 350.0 | monetaryItemType | text: <entity> 350.0 </entity> <entity type> monetaryItemType </entity type> <context> In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. </context> | us-gaap:OperatingLossCarryforwards |
In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. | text | 141.2 | monetaryItemType | text: <entity> 141.2 </entity> <entity type> monetaryItemType </entity type> <context> In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. </context> | us-gaap:OperatingLossCarryforwards |
In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. | text | 8.3 | monetaryItemType | text: <entity> 8.3 </entity> <entity type> monetaryItemType </entity type> <context> In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. </context> | us-gaap:OperatingLossCarryforwards |
In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. | text | 155.7 | monetaryItemType | text: <entity> 155.7 </entity> <entity type> monetaryItemType </entity type> <context> In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. </context> | us-gaap:OperatingLossCarryforwards |
In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. | text | 131.6 | monetaryItemType | text: <entity> 131.6 </entity> <entity type> monetaryItemType </entity type> <context> In the U.S. and Switzerland, the Company has net operating loss carryforwards of $ 97.3 million and $ 350.0 million respectively. Under applicable law, the U.S. and Swiss net operating loss carryforwards will begin to expire in 2037 and 2025 respectively. The Company has net operating loss carryforwards of $ 141.2 million in the U.K., $ 8.3 million in Ireland, and $ 155.7 million in Luxembourg. Under applicable law, the U.K., Ireland and Luxembourg net operating losses can be carried forward for an indefinite period. The Company has capital loss carryforwards of $ 131.6 million in the U.S. that begin to expire in 2027. The Company has unrealized losses in the U.S. investment portfolio of $ 60.6 million. These unrealized investment losses do not expire. However, if realized, these losses may only offset realized capital gains and would expire, if unused, at the end of the fifth taxable year following their realization. </context> | us-gaap:OperatingLossCarryforwards |
The Company made net payments for U.S. federal and state, Canada, Ireland, U.K., Singapore, Switzerland and Australia income taxes of $ 99.5 million for the year ended 2024 (2023 - net payments of $ 26.8 million, 2022 - net payments of $ 3.1 million). | text | 99.5 | monetaryItemType | text: <entity> 99.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company made net payments for U.S. federal and state, Canada, Ireland, U.K., Singapore, Switzerland and Australia income taxes of $ 99.5 million for the year ended 2024 (2023 - net payments of $ 26.8 million, 2022 - net payments of $ 3.1 million). </context> | us-gaap:IncomeTaxesPaidNet |
The Company made net payments for U.S. federal and state, Canada, Ireland, U.K., Singapore, Switzerland and Australia income taxes of $ 99.5 million for the year ended 2024 (2023 - net payments of $ 26.8 million, 2022 - net payments of $ 3.1 million). | text | 26.8 | monetaryItemType | text: <entity> 26.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company made net payments for U.S. federal and state, Canada, Ireland, U.K., Singapore, Switzerland and Australia income taxes of $ 99.5 million for the year ended 2024 (2023 - net payments of $ 26.8 million, 2022 - net payments of $ 3.1 million). </context> | us-gaap:IncomeTaxesPaidNet |
The Company made net payments for U.S. federal and state, Canada, Ireland, U.K., Singapore, Switzerland and Australia income taxes of $ 99.5 million for the year ended 2024 (2023 - net payments of $ 26.8 million, 2022 - net payments of $ 3.1 million). | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company made net payments for U.S. federal and state, Canada, Ireland, U.K., Singapore, Switzerland and Australia income taxes of $ 99.5 million for the year ended 2024 (2023 - net payments of $ 26.8 million, 2022 - net payments of $ 3.1 million). </context> | us-gaap:IncomeTaxesPaidNet |
On May 16, 2022, the Company’s shareholders approved the Company’s First Amended and Restated 2016 Long-Term Incentive Plan, which amended and restated the plan initially approved by the shareholders in May 2016 (as amended from time to time, the “2016 Long-Term Incentive Plan”). The Company is authorized to issue up to 3,060,092 common shares pursuant to the 2016 Long-Term Incentive Plan. The 2016 Long-Term Incentive Plan permits the grant of restricted stock awards, restricted stock units, performance share awards (including cash-based performance awards), stock options and other share-based awards to employees, officers, non-employee directors and consultants or advisors of the Company and its affiliates. | text | 3060092 | sharesItemType | text: <entity> 3060092 </entity> <entity type> sharesItemType </entity type> <context> On May 16, 2022, the Company’s shareholders approved the Company’s First Amended and Restated 2016 Long-Term Incentive Plan, which amended and restated the plan initially approved by the shareholders in May 2016 (as amended from time to time, the “2016 Long-Term Incentive Plan”). The Company is authorized to issue up to 3,060,092 common shares pursuant to the 2016 Long-Term Incentive Plan. The 2016 Long-Term Incentive Plan permits the grant of restricted stock awards, restricted stock units, performance share awards (including cash-based performance awards), stock options and other share-based awards to employees, officers, non-employee directors and consultants or advisors of the Company and its affiliates. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
There were 0.8 million shares available for issuance under the 2016 Long-Term Incentive Plan at December 31, 2024. | text | 0.8 | sharesItemType | text: <entity> 0.8 </entity> <entity type> sharesItemType </entity type> <context> There were 0.8 million shares available for issuance under the 2016 Long-Term Incentive Plan at December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). | text | 82.8 | monetaryItemType | text: <entity> 82.8 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). | text | 70.0 | monetaryItemType | text: <entity> 70.0 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). | text | 38.8 | monetaryItemType | text: <entity> 38.8 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> The aggregate fair value of restricted stock awards and performance share awards vested during 2024 was $ 82.8 million (2023 - $ 70.0 million, 2022 - $ 38.8 million). In connection with share vestings, there was a $ 2.0 million excess windfall tax benefit realized by the Company in 2024 (2023 - $ 1.7 million, 2022 - $ 0.1 million). </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. | text | 71.4 | monetaryItemType | text: <entity> 71.4 </entity> <entity type> monetaryItemType </entity type> <context> The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. </context> | us-gaap:ShareBasedCompensation |
The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. | text | 60.3 | monetaryItemType | text: <entity> 60.3 </entity> <entity type> monetaryItemType </entity type> <context> The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. </context> | us-gaap:ShareBasedCompensation |
The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. | text | 45.2 | monetaryItemType | text: <entity> 45.2 </entity> <entity type> monetaryItemType </entity type> <context> The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. </context> | us-gaap:ShareBasedCompensation |
The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. | text | 107.6 | monetaryItemType | text: <entity> 107.6 </entity> <entity type> monetaryItemType </entity type> <context> The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. | text | 17.8 | monetaryItemType | text: <entity> 17.8 </entity> <entity type> monetaryItemType </entity type> <context> The total stock compensation expense recognized in the Company’s consolidated statements of operations during 2024 was $ 71.4 million (2023 - $ 60.3 million, 2022 - $ 45.2 million). As of December 31, 2024, there was $ 107.6 million of total unrecognized compensation cost related to restricted stock awards and $ 17.8 million related to performance share awards, which will be recognized on a weighted average basis during the next 1.8 years and 1.8 years, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
All of the Company’s employees are eligible for defined contribution pension plans. Contributions are primarily based upon a percentage of eligible compensation. The Company contributed $ 12.0 million to its defined contribution pension plans in 2024 (2023 - $ 9.5 million, 2022 - $ 6.7 million). | text | 12.0 | monetaryItemType | text: <entity> 12.0 </entity> <entity type> monetaryItemType </entity type> <context> All of the Company’s employees are eligible for defined contribution pension plans. Contributions are primarily based upon a percentage of eligible compensation. The Company contributed $ 12.0 million to its defined contribution pension plans in 2024 (2023 - $ 9.5 million, 2022 - $ 6.7 million). </context> | us-gaap:DefinedContributionPlanCostRecognized |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.